49 related articles for article (PubMed ID: 11768613)
1. Mutation status of genes encoding RhoA, Rac1, and Cdc42 GTPases in a panel of invasive human colorectal and breast tumors.
Rihet S; Vielh P; Camonis J; Goud B; Chevillard S; de Gunzburg J
J Cancer Res Clin Oncol; 2001 Dec; 127(12):733-8. PubMed ID: 11768613
[TBL] [Abstract][Full Text] [Related]
2. Selectivity Determinants of RHO GTPase Binding to IQGAPs.
Mosaddeghzadeh N; Nouri K; Krumbach OHF; Amin E; Dvorsky R; Ahmadian MR
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830479
[TBL] [Abstract][Full Text] [Related]
3. Role of Nrf2 Signaling Cascade in Breast Cancer: Strategies and Treatment.
Kumar H; Kumar RM; Bhattacharjee D; Somanna P; Jain V
Front Pharmacol; 2022; 13():720076. PubMed ID: 35571115
[TBL] [Abstract][Full Text] [Related]
4. Could cell division cycle protein 42 be a target for lung cancer treatment?
Lv J; Song Y
Transl Cancer Res; 2019 Feb; 8(1):312-318. PubMed ID: 35116760
[TBL] [Abstract][Full Text] [Related]
5. EFA6B regulates a stop signal for collective invasion in breast cancer.
Fayad R; Rojas MV; Partisani M; Finetti P; Dib S; Abelanet S; Virolle V; Farina A; Cabaud O; Lopez M; Birnbaum D; Bertucci F; Franco M; Luton F
Nat Commun; 2021 Apr; 12(1):2198. PubMed ID: 33850160
[TBL] [Abstract][Full Text] [Related]
6. B3GNT3 acts as a carcinogenic factor in endometrial cancer via facilitating cell growth, invasion and migration through regulating RhoA/RAC1 pathway-associated markers.
Wang JS; Ruan F; Guo LZ; Wang FG; Wang FL; An HM
Genes Genomics; 2021 May; 43(5):447-457. PubMed ID: 33683574
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of Cdc42-intersectin interaction by small molecule ZCL367 impedes cancer cell cycle progression, proliferation, migration, and tumor growth.
Aguilar BJ; Zhao Y; Zhou H; Huo S; Chen YH; Lu Q
Cancer Biol Ther; 2019; 20(6):740-749. PubMed ID: 30849276
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of CDC42SE1 in A431 Cells Reduced Cell Proliferation by Inhibiting the Akt Pathway.
Kalailingam P; Tan HB; Pan JY; Tan SH; Thanabalu T
Cells; 2019 Feb; 8(2):. PubMed ID: 30717410
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of Dock1 and Elmo1 suppresses the migration and invasion of triple-negative breast cancer epithelial cells through the RhoA/Rac1 pathway.
Liang Y; Wang S; Zhang Y
Oncol Lett; 2018 Sep; 16(3):3481-3488. PubMed ID: 30127952
[TBL] [Abstract][Full Text] [Related]
10. Cell Division Cycle 42 plays a Cell type-Specific role in Lung Tumorigenesis.
Zheng C; Wang Y; Yang L; Zhou S; Gao Y; Li F; Feng Y; Wang Z; Zhan L; Yan Q; Zhu X; Wong KK; Chen Z; Ji H
Sci Rep; 2017 Sep; 7(1):10407. PubMed ID: 28871124
[TBL] [Abstract][Full Text] [Related]
11. Epithelial cell migration as a potential therapeutic target in early lung cancer.
Millar FR; Janes SM; Giangreco A
Eur Respir Rev; 2017 Jan; 26(143):. PubMed ID: 28143875
[TBL] [Abstract][Full Text] [Related]
12. NRF2 promotes breast cancer cell proliferation and metastasis by increasing RhoA/ROCK pathway signal transduction.
Zhang C; Wang HJ; Bao QC; Wang L; Guo TK; Chen WL; Xu LL; Zhou HS; Bian JL; Yang YR; Sun HP; Xu XL; You QD
Oncotarget; 2016 Nov; 7(45):73593-73606. PubMed ID: 27713154
[TBL] [Abstract][Full Text] [Related]
13. Whole-Genome Sequencing of Salivary Gland Adenoid Cystic Carcinoma.
Rettig EM; Talbot CC; Sausen M; Jones S; Bishop JA; Wood LD; Tokheim C; Niknafs N; Karchin R; Fertig EJ; Wheelan SJ; Marchionni L; Considine M; Ling S; Fakhry C; Papadopoulos N; Kinzler KW; Vogelstein B; Ha PK; Agrawal N
Cancer Prev Res (Phila); 2016 Apr; 9(4):265-74. PubMed ID: 26862087
[TBL] [Abstract][Full Text] [Related]
14. RhoA and RhoC differentially modulate estrogen receptor α recruitment, transcriptional activities, and expression in breast cancer cells (MCF-7).
Malissein E; Meunier E; Lajoie-Mazenc I; Médale-Giamarchi C; Dalenc F; Doisneau-Sixou SF
J Cancer Res Clin Oncol; 2013 Dec; 139(12):2079-88. PubMed ID: 24096540
[TBL] [Abstract][Full Text] [Related]
15. Cdc42 overexpression induces hyperbranching in the developing mammary gland by enhancing cell migration.
Bray K; Gillette M; Young J; Loughran E; Hwang M; Sears JC; Vargo-Gogola T
Breast Cancer Res; 2013; 15(5):R91. PubMed ID: 24074261
[TBL] [Abstract][Full Text] [Related]
16. Targeting Cdc42 in cancer.
Arias-Romero LE; Chernoff J
Expert Opin Ther Targets; 2013 Nov; 17(11):1263-73. PubMed ID: 23957315
[TBL] [Abstract][Full Text] [Related]
17. ERM/Rho protein expression in ductal breast cancer: a 15 year follow-up.
Halon A; Donizy P; Surowiak P; Matkowski R
Cell Oncol (Dordr); 2013 Jun; 36(3):181-90. PubMed ID: 23420497
[TBL] [Abstract][Full Text] [Related]
18. Small molecule targeting Cdc42-intersectin interaction disrupts Golgi organization and suppresses cell motility.
Friesland A; Zhao Y; Chen YH; Wang L; Zhou H; Lu Q
Proc Natl Acad Sci U S A; 2013 Jan; 110(4):1261-6. PubMed ID: 23284167
[TBL] [Abstract][Full Text] [Related]
19. Rho GTPases and their roles in cancer metabolism.
Wilson KF; Erickson JW; Antonyak MA; Cerione RA
Trends Mol Med; 2013 Feb; 19(2):74-82. PubMed ID: 23219172
[TBL] [Abstract][Full Text] [Related]
20. Novel roles of Skp2 E3 ligase in cellular senescence, cancer progression, and metastasis.
Wang G; Chan CH; Gao Y; Lin HK
Chin J Cancer; 2012 Apr; 31(4):169-77. PubMed ID: 22200179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
